DirectorThrombosis Research Institute, London, UKLondon, England, United Kingdom
President, Thrombosis Research (TRI) London, England, UK
PB0049 - Thromboprophylaxis with enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: Pooled analysis of the OVID and ETHIC trials
Sunday, June 25, 202318:30 – 19:30 ET